Home › Neuroendocrine Tumors › Kentucky
Neuroendocrine Tumors clinical trials in Kentucky
4 studies for Neuroendocrine Tumors are looking for participants at sites in Kentucky.
Cities in Kentucky
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Research Facility, Lexington
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07165132Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Kentucky Markey Cancer Center, Lexington
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06943755Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- University of Kentucky, Lexington
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Oct 13, 2026 · NCT05636618Project: Every Child for Younger Patients With Cancer
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.